rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Jack W. Schuler

10% owner and Other role

Company insider

Files Form 4 as: Director and 10% owner and Other, Biodesix; 10% owner, Aspira Women's Health; Director and 10% owner, Accelerate Diagnostics; 10% owner, Yield10 Bioscience; 10% owner, Soleno Therapeutics; Director and 10% owner, Quidel Corp /de/; 10% owner, Biolase; Chairman, Stericycle.

Every Form 4 they filed

In numbers

Trades disclosed
1,314
Buys
339
Sells
170
Bought
$337.6M
Sold
$104.1M
Companies
15
Companies where not an officer
14
First trade
27 Jan 2006
Last trade
12 Aug 2026
Last filed
13 Aug 2026

Companies traded

Where they are an officer
StericycleDirector, Officer · last 30 Apr 20184 buys · 19 sells
Everywhere else they filed: board seats, 10% stakes, other companies
BDSX BiodesixDirector, 10% owner, Other · Diagnostics & Labs · last 12 Aug 202644 buys · 0 sells
Aspira Women's Health10% owner · last 5 Jun 202621 buys · 0 sells
Accelerate DiagnosticsDirector, 10% owner · last 3 Dec 2024128 buys · 1 sell
Yield10 Bioscience10% owner · last 20 Dec 20239 buys · 50 sells
Soleno Therapeutics10% owner · last 9 Dec 202234 buys · 79 sells
Quidel Corp /de/Director, 10% owner · last 14 May 202018 buys · 12 sells
Biolase10% owner · last 11 Feb 202037 buys · 1 sell
Neos Therapeutics10% owner · last 28 Jul 20151 buy · 0 sells
Hansen MedicalDirector, 10% owner · last 15 Jun 20150 buys · 0 sells
Gtx Inc /de/Director, 10% owner · last 21 Mar 201430 buys · 6 sells
MedtronicDirector · last 10 May 201312 buys · 2 sells
Transition Therapeutics10% owner · last 22 Nov 20111 buy · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
104Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
12 Aug 2026filed 13 Aug 2026BDSX BiodesixDiagnostics & LabsSEC FORM 4 Bought$367K15,000 at $24.47filing
12 Aug 2026filed 13 Aug 2026BDSX BiodesixDiagnostics & LabsSEC FORM 4 Bought$367K15,000 at $24.47filing
11 Aug 2026filed 12 Aug 2026BDSX BiodesixDiagnostics & LabsSEC FORM 4 Bought$329K13,700 at $24.01filing
11 Aug 2026filed 12 Aug 2026BDSX BiodesixDiagnostics & LabsSEC FORM 4 Bought$329K13,700 at $24.01filing
10 Aug 2026filed 12 Aug 2026BDSX BiodesixDiagnostics & LabsSEC FORM 4 Bought$337K13,900 at $24.25filing
10 Aug 2026filed 12 Aug 2026BDSX BiodesixDiagnostics & LabsSEC FORM 4 Bought$337K13,900 at $24.25filing
5 Jun 2026filed 9 Jun 2026Aspira Women's HealthSEC FORM 4 Bought$100K222,222 at $0.45filing
5 Jun 2026filed 9 Jun 2026Aspira Women's Healthoption or derivativeSEC FORM 4 Code P—300,000 at $0.00filing
5 Jun 2026filed 9 Jun 2026Aspira Women's Healthoption or derivativeSEC FORM 4 Code P—300,000 at $0.00filing
5 Jun 2026filed 9 Jun 2026Aspira Women's HealthSEC FORM 4 Bought$100K222,222 at $0.45filing
26 Jan 2026filed 27 Jan 2026BDSX BiodesixDiagnostics & LabsSEC FORM 4 Bought$236K20,000 at $11.80filing
26 Jan 2026filed 27 Jan 2026BDSX BiodesixDiagnostics & LabsSEC FORM 4 Bought$236K20,000 at $11.80filing
23 Jan 2026filed 27 Jan 2026BDSX BiodesixDiagnostics & LabsSEC FORM 4 Bought$945K80,000 at $11.81filing
23 Jan 2026filed 27 Jan 2026BDSX BiodesixDiagnostics & LabsSEC FORM 4 Bought$945K80,000 at $11.81filing
22 Jan 2026filed 26 Jan 2026BDSX BiodesixDiagnostics & LabsSEC FORM 4 Bought$904K82,465 at $10.96filing
22 Jan 2026filed 26 Jan 2026BDSX BiodesixDiagnostics & LabsSEC FORM 4 Bought$904K82,465 at $10.96filing
19 Sep 2025filed 23 Sep 2025BDSX BiodesixDiagnostics & LabsSEC FORM 4 Bought$1000K142,045 at $7.04filing
18 Sep 2025filed 19 Sep 2025BDSX BiodesixDiagnostics & LabsSEC FORM 4 Bought$19K3,056 at $6.17filing
17 Sep 2025filed 19 Sep 2025BDSX BiodesixDiagnostics & LabsSEC FORM 4 Bought$93K15,317 at $6.04filing
17 Sep 2025filed 19 Sep 2025Aspira Women's Healthoption or derivativeSEC FORM 4 Code P—833,333 at $0.00filing

The newest 500 lines are listed; the numbers count every line.

Sectors

Health Care44
Not placed465

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.